Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study

Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study

Background: The development of biomarkers predictive of response to immune checkpoint inhibitor (ICI) therapies in advanced melanoma is an area of great interest in oncology. Our study evaluated the potential role of serum vascular endothelial growth factor (VEGF) as a predictive biomarker of clinic...

Full description

Bibliographic Details
Main Authors: Muhammad A. Khattak, Afaf Abed, Anna L. Reid, Ashleigh C. McEvoy, Michael Millward, Melanie Ziman, Elin S. Gray
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Oncology
Subjects:
immunotherapy
vascular endothelial growth factor
melanoma
biomarker
ipilimumab
pembrolizumab
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01041/full

Similar Items

Similar Items